Anastasios G. Konstas

Thessaloniki, ESYE12, Greece

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications

An Update and Overview of the Ocular and Extraocular Microbiome and Its Impact on Ophthalmic Care.

An Update and Overview of the Ocular and Extraocular Microbiome and Its Impact on Ophthalmic Care.

Journal: Advances in therapy
Published: March 03, 2026

Branded Compared with Generic Latanoprost in Glaucoma Therapy: Where Do We Stand?

Branded Compared with Generic Latanoprost in Glaucoma Therapy: Where Do We Stand?

Journal: Advances in therapy
Published: October 23, 2025

In silico trials in ocular drug development: a new frontier in ophthalmology.

In silico trials in ocular drug development: a new frontier in ophthalmology.

Journal: Expert opinion on drug discovery
Published: September 05, 2025

Preservative-Free Gel-Formulated Glaucoma Therapies: Learning from the Past, Looking to the Future.

Preservative-Free Gel-Formulated Glaucoma Therapies: Learning from the Past, Looking to the Future.

Journal: Advances in therapy
Published: July 09, 2025

A Study of 24-h Efficacy and Safety of Sepetaprost vs. Latanoprost in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension.

A Study of 24-h Efficacy and Safety of Sepetaprost vs. Latanoprost in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension.

Journal: Advances in therapy
Published: February 26, 2025

A New Technique with Scleral Grooves for Sutureless Scleral Fixation of the Carlevale Intraocular Lens.

A New Technique with Scleral Grooves for Sutureless Scleral Fixation of the Carlevale Intraocular Lens.

Journal: Ophthalmology and therapy
Published: April 18, 2024

Acute Corneal Melting Induced by the Concomitant Use of a Non-steroidal Anti-inflammatory Agent with an Antiseptic Eye Drop.

Acute Corneal Melting Induced by the Concomitant Use of a Non-steroidal Anti-inflammatory Agent with an Antiseptic Eye Drop.

Journal: Ophthalmology and therapy
Published: October 11, 2023

Development and Validation of the Life for Low Vision Questionnaire (LIFE4LVQ) Using Rasch Analysis: A Questionnaire Evaluating Ability and Independence.

Development and Validation of the Life for Low Vision Questionnaire (LIFE4LVQ) Using Rasch Analysis: A Questionnaire Evaluating Ability and Independence.

Journal: Journal of clinical medicine
Published: January 08, 2023

Changing from preserved, to preservative-free cyclosporine 0.1% enhanced triple glaucoma therapy: impact on ocular surface disease-a randomized controlled trial.

Changing from preserved, to preservative-free cyclosporine 0.1% enhanced triple glaucoma therapy: impact on ocular surface disease-a randomized controlled trial.

Journal: Eye (London, England)
Published: October 26, 2022

Evaluation of a Novel Αb Εxterno MicroShunt for the Treatment of Glaucoma.

Evaluation of a Novel Αb Εxterno MicroShunt for the Treatment of Glaucoma.

Journal: Advances in therapy
Published: April 21, 2022

Emerging Treatment Modalities for Neovascular Age-Related Macular Degeneration: A Systematic Overview.

Emerging Treatment Modalities for Neovascular Age-Related Macular Degeneration: A Systematic Overview.

Journal: Advances in therapy
Published: September 02, 2021

Dorzolamide/Timolol Fixed Combination: Learning from the Past and Looking Toward the Future.

Dorzolamide/Timolol Fixed Combination: Learning from the Past and Looking Toward the Future.

Journal: Advances in therapy
Published: August 25, 2020
Showing 1-12 of 46

Last Updated: 09/26/2026